GBV-A10 [P16L]

General Information


DRACP ID  DRACP04003

Peptide Name   GBV-A10 [P16L]

Sequence  CWVRLGRYLLRRLKTLFT

Sequence Length  18

UniProt ID  O41892 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C107H176N32O22S

Absent amino acids  ADEHIMNPQS

Common amino acids  L

Mass  259824

Pl  12.06

Basic residues  5

Acidic residues  0

Hydrophobic residues  8

Net charge  5

Boman Index  -3434

Hydrophobicity  14.44

Aliphatic Index  124.44

Half Life 
  Mammalian: 1 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  6990

Absorbance 280nm  411.18

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23175359

Title  Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A

Doi Not available

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  15442

DRACP is developed by Dr.Zheng's team.